Latest Liver biopsy Stories
Palpation continues to be of great value in modern medicine, both practiced by doctors and as a technique for self-examination; however, palpation is limited to a few accessible organs, and the interpretation of the information sensed by the fingers is highly subjective.
As a result of the rarity of Wilson disease (WD) and the fact that liver biopsy is not performed routinely during follow-up, unless clinically indicated, the progression and timing of the liver pathology and its correlation with different anti-copper treatments or aminotransferase levels are poorly characterized.
NAFLD and NASH patients at greater risk of death than the general population.
Sonic detection of liver stiffness emerges as a useful screening and prognostic test.
A major clinical challenge is to find the best method to evaluate and to manage the increasing numbers of patients with chronic liver disease.
MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients.
Liver biopsy is still considered the gold standard for grading, staging and "stad-ging" the chronic liver disease.
Imaging technology can identify liver fibrosis with high accuracy, limiting the need for biopsies to diagnose diseases, U.S. researchers say. Dr.
Bristol-Myers Squibb Company (NYSE:BMY) today announced data from two separate cohort evaluations, in which long-term treatment with BARACLUDE(R) (entecavir) was associated with improved liver histology, including improvement in fibrosis, in chronic hepatitis B patients.
A Chinese-led study has found non-invasive transient elastography can measure liver stiffness, accurately diagnosing patients with late-stage liver disease. The researchers, led by Dr.